Main menu


Pfizer calls on the FDA to expand emergency use of the Corona vaccine to children

Pfizer asked the US Food and Drug Administration (FDA) to expand emergency use of the Corona vaccine to Americans between the ages of 12 and 15 years, when when the vaccine was authorized for use by the Food and Drug Administration in December 2020, the vaccine was only intended for those aged 16 and over. Above, but recently, according to the report of the newspaper "dailymail", data from clinical trials of the third stage showed that the vaccine is 100% safe and effective in younger adolescents.

According to the report, if approved by the US Food and Drug Administration, children between the ages of 12 and 15 can be vaccinated against the Corona virus before the start of the next school year.

In a statement on Twitter, the New York-based drug company said it plans to seek similar provisions in other countries that use the vaccine, and in the trial, about 2,200 teens were registered in the United States compared to 40,000 for a teenager 16 years old or older.

Half of the group received two doses of the vaccine three weeks apart, while the other half received two placebo injections, and a total of 18 cases of corona vaccine were reported in the placebo group, while no cases were reported in the vaccine group.

 The researchers plan to track the participants for two years to gather long-term protection, effects and safety information.

It is unclear how long the FDA will take to review the data, but CDC Director Rochelle Walsky told ABC News that she expects the Pfizer vaccine to be licensed for children ages 12 to 15 by mid-May.

Although children are less likely to contract severe coronavirus or develop complications, health experts say giving children and adolescents the vaccine is a critical step in the United States' access to "herd immunity."

Children are often the last group to be tested during clinical trials, as their bodies and immune systems behave differently.